Abstract Despite the recent introduction of tissue harmonic imaging in echocardiography, 10-15% of patients have poor endocardia[ border definition. This may lead to erroneous assessment of regional and global [eft ventMcu[ar (LV) function or to further diagnostic imaging with another moda[ity thus increasing the costs for the hea[thcare system. The recent development of second generation contrast echocardiography agents such as SonoVue has resulted in several studies showing the value of these agents to outline endocardium dearly, thereby improving assessment of LV function. The use of these contrast agents has also opened the possibility of automated and quantitative LV function assessment, making it more accurate and reproducible. Other major clinical uses of these contrast agents are evaluation of LV masses such as thrombus and tumors, and better definition of LV structure such as delineating LV aneurysm, pseudoaneurysm; and non-compaction of LV and apical cardiomyopathy. Furthermore, the use of these contrast agents during stress not only improved the assessment of watt motion but also made possible the evaluation of myocardial perfusion, thereby increasing diagnostic accuracy for the detection of coronary artery disease.
Introduction
Accurate assessment of regionat and gtobat teft ventricutar (LV) function and structure is pivotat in the ctinicat management of patients with suspected cardiovascutar disease. Severat studies have previousty confirmed that markers of LV function such as LV ejection fraction (LVEF), watt motion score indices, end-systotic votume and regionat watt motion assessment are powerfut predictors of outcome in patients with cardiac disease ~-6. Indeed, markers of LV remodetting fottowing acute myocardiat infarction in patients with heart faiture are even more powerfut indices of outcome 7-9. White echocardiography is the most widety used and inexpensive toot for the assessment of cardiac structure and function, it is unabte to obtain adequate images in about 30% of patients 1°, 11 The inabitity to ctearty identify endocardia[ border has resutted in unacceptabte reproducibitity for assessment of LVEF and regiona[ watt thickness 12,~3 Furthermore, in day to day ctinica[ practice, assessment of markers of LV function by echocardiography has been quatitative, subjective and experience dependent ~4. This has atso resutted in suboptima[ efficacy for the detection of coronary artery disease during stress echocardiography. Figure 4 shows an example where tissue harmonic imaging failed to identify endocardia[ border in the apicolateral wall, which was brought out clearly by contrast echocardiography. In another study, Spencer et at. 23 demonstrated in a large group of patients with poor images that contrast enhancement resulted in a significantly higher segmental salvage rate compared to harmonic imaging alone. measured these from data acquired before and after intravenous contrast echocardio~raphy and compared these measurements with quantitative assessments obtained by magnetic resonance ima~in~. The use of contrast improved the echocardio~raphic assessment of LV volumes and WEE The percentage of subjects in whom the correct echocardio~raphic classification of normal, mild to moderately reduced or severely depressed LVEF was achieved improved significantly after contrast enhancement. These findings were most strikin~ in study subjects who had two or more adjacent poorly visualised segments. However, in a lar~er study consistin~ of 110 patients, the accuracy of intravenous contrast echocardio~raphy was found to be significantly better than unenhanced tissue harmonic ima~in~ when compared to CMR irrespective of image quality 25. The LV volumes assessed by tissue harmonic ima~in~ were consistently smatter, while those assessed durin~ contrast echocardio~raphy were less small compared to CMR. This is probably because tissue harmonic does not track the endocardium as well as contrast echocardio~raphy and hence results in trackin~ noise in the left ventricle cavity, which is perceived as endocardial border. In this study contrast echocardio~raphy was also more reproducible than tissue harmonic echocardio~raphy. This fact was further demonstrated in a multicentre study usin~ SonoVue 26.
Does contrast echocardiography improve assessment of
Recently the advent of low-power contrast echocardio~raphy has allowed simultaneous as-sessment of myocardia[ perfusion and function. White tow-power myocardia[ perfusion has been extensivety investigated, the abitity of this technique to assess LV function was not extensivety studied. However, a recent study, which atready had investigated the usefutness of detection of myocardia[ perfusion fottowin~ AMI, further evatuated the abitity of contrast echocardio~raphy to assess LV remodettin~ 7-10 days after AM127. At[ patients atso underwent CMR at 7-10 days after AMI. Low-power contrast echocardio~raphy was more accurate and reproducibte than tissue harmonic ima~in~ when CMR was considered the standard. Furthermore, tow-power contrast echocardio~raphy correctty identified patients with various ~rades of WEE This is important because LVEF after AMI is one of the major determinants not onty of outcome but for decision-makin~ re~ardin~ imptantation of an automatic defibrittator.
In 
Imaging techniques for assessment of L¥ function
Evidence suggests that harmonic contrast echocardio~raphy ~ives the best si~nat-to-noise ratio for LV opacification. However, high transmit power may resutt in apica[ microbubbte destruction. Furthermore, high transmit power due to its ~reater bubbte destruction effect may atso resutt in tarter votumes of contrast to be injected in patients with farce cardiac votumes to adequatety opacify LV for proper endocardia[ definition. Thus, to minimise bubbte destruction especiatty at the apex durin~ contrast harmonic echocardio~raphy, the transmit power shoutd be reduced to intermediate tevets and foca[ zone shoutd be kept at intermediate depth. When mechanica[ index (MI) is used to define transmit power, an MI of >1 is high. It shoutd be reduced to 0.5-0.6. With the advent of tow-power ima~in~ technoto~ies, i.e. power putse inversion, power modutation and coherent ima~in~, one can now achieve even better segmentation of LV cavity from the myocardia[ tissue. However, the frame rate drops quite si~nificantty, but recent devetopments have resutted in improvin~ the frame rate to approximatety 25-30 MHz. Other applications of L¥ contrast opacification Assessment of LV thrombus remains a difficult entity even with harmonic tissue ima~in~. Harmonic ~eneration is poor in the near field 32 Noise, clutter and reverberation in the near field make fundamental echocardio~raphy an almost useless technique to confidently identify apical masses. Contrast echocardio~raphy under these circumstances provides unequivocal diagnosis (fi~. 6). This has been clearly shown in a recent study by Thani~araj et aL 33 Another condition of the heart that may prove elusive to diagnosis by native echocardio~raphy is apical hypertrophic cardiomyopathy. A recent case report from our laboratory clearly showed the utility of contrast echocardio~raphy for the diagnosis of this entity 34 (fi~. 7). Non-compaction of LV has recently been identified in more patients with the advent of contrast echocardio~raphy.
Automated quantification of LV function

Stress echocardiography
One of the major challenges of modern cardiology is the detection or exclusion of flow-[imitin~ coronary artery disease (CAD). Stress echocardio~raphy is an established diagnostic method for the assessment of myocardial ischemia. Its widespread availability, feasibility in almost a[[ circumstances, non-invasiveness, and relatively low cost has led to ~enera[ acceptance of this diagnostic method. Interpretation of both pharmacologic and dynamic stress echocardio~raphy is based on the evaluation of LV wail thickenin~ and motion at rest and durin~ stress. 
Diagnostic value of contrast stress echocardiography
Although improvement of LV visualization and reader confidence has been described in numerous studies, the impact on the diagnostic yield of stress echocardiography has not been investigated in depth. Uehara and coworkers 43 reported improvement of the diagnostic accuracy for the circumflex artery only, this was due to most pronounced enhancement of endocardia[ border delineation in the [atera[ wa[[ of the LV corresponding to the perfusion bed of this vessel. Another study ~ compared sensitivity and specificity of dobutamine stress echocardiography in 112 patients with good LV visua[ization at rest with that in 117 patients with poor image qua[ity during native imaging who underwent contrast echocardiography. These investigators found that in patients with poor image quality the use of contrast during dobutamine stress echocardiography significantly improved endocardia[ border delineation and resulted in a sensitivity and specificity for detection of CAD, comparable to that achieved with the native dobutamine stress in patients with good image qua[ity.
The ability of contrast echocardiograpy to simu[taneous[y assess perfusion potentia[[y makes stress echocardiography a sensitive technique to detect flow-[imiting CAD. Experimenta[ studies have c[ear[y indicated that identification of perfusion defect enhances the ability of dobutamine echocardiography not only to detect flow-limiting CAD but also to correctly identify multi-vessel disease, which has prognostic importance 45, 46 . Recent clinical studies have indicated that myocardial perfusion abnormality detection significantly enhanced the ability of dobutamine echocardiography for the detection of CAD 47-49. In those patients who are unable to exercise or undergo dobutamine echocardiography (e.g. lifethreatening arrhythmias, severe LV dysfunction) or when these tests are difficult to interpret, (e.g. LBBB, pacing, systemic etc), vasodi[ator myocardial contrast echocardiography may be performed. Vasodi[ator MCE has been found to be accurate and even superior to SPECT for the detection of CAD 50,51
In a novel study, Moir et aL 52 used a dipyridamo[e-exercise MCE protocol whereby watt motion assessment was maximised, and exercise parameters were obtained together with data on myocardial perfusion. They found that watt motion assessment without contrast underestimated diagnosis and extent of CAD compared to watt motion and perfusion assessment using tow-power MCE 52
Conclusion
Contrast echocardiography, both at rest and stress, provides valuable clinical information by at[owing simultaneous assessment of both function and perfusion at rest and during stress.
